Geron Corp (NASDAQ:GERN)

CAPS Rating: 3 out of 5

A biopharmaceutical company which is developing first-in-class therapeutic products for the treatment of cancer and chronic degenerative diseases, including spinal cord injury, heart failure, diabetes and HIV/AIDS.

Recs

0
Player Avatar lipripper (< 20) Submitted: 12/2/2010 9:29:26 PM : Outperform Start Price: $5.86 GERN Score: -83.92

this one I believe has a big growth story waiting on it-Im in at 5.74

Featured Broker Partners


Advertisement